88IV - PR Newswire Asia's news - Medical/Pharmaceuticals


WuXi Biologics Singapore CRDMO Hub Advances with the Launch of Modular Drug Product Facility Fabrication Innovative modular design will accelerate construction and manufacturing timelines, enabling rapid adaptation of manufacturing capacities across diverse product formats. Finished building will be one ... 2025-07-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Alphamab Oncology Announces Anti-HER2 Biparatopic ADC JSKN003 Obtained Orphan Drug Designation from the U.S. FDA for the Treatment of GC/GEJ SUZHOU, China , July 29, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has been granted Orphan Drug Designation ... 2025-07-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2025: U.S. POINTER STUDY SHOWS STRUCTURED LIFESTYLE PROGRAM TARGETING MULTIPLE RISK FACTORS IMPROVES COGNITION IN OLDER ADULTS AT RISK OF COGNITIVE DECLINE Key Takeaways ... 2025-07-29T Health Care/Hospital Medical/Pharmaceuticals
XellSmart Completed World's First Patient Dosing in its Registrational Clinical trial for iPSC-derived Subtype-specific Neural Cell Therapy for Spinal Cord Injury SUZHOU, China , July 28, 2025 /PRNewswire/ -- XellSmart Biopharmaceutical (Suzhou/ Shanghai ) Co., Ltd. achieved a significant milestone in its "world's first" China NMPA & US ... 2025-07-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Big Lake Capital, LLC, Led and Controlled by NMHI CEO, Converts $671,984 Note into Nature's Miracle ("NMHI") Common Stocks ONTARIO, Calif. , July 28, 2025 /PRNewswire/ -- Nature's Miracle Holding Inc. (NMHI) ("Nature's Miracle" or the "Company"), a leader in vertical farming technology announce that ... 2025-07-28T Agriculture Banking/Financial Service Medical/Pharmaceuticals
Alamar Biosciences Showcases Pioneering Brain-Derived pTau Data at the Alzheimer's Association International Conference (AAIC) Groundbreaking Insights into Neurodegenerative Disease Biomarkers to be Unveiled through 30+ Posters and Presentations at International Meeting ... 2025-07-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals Trade show news
Antengene Announces XPOVIO® Approved in China for the Second-Line Treatment of Multiple Myeloma, Marking the Third Approved Indication of the Drug - This approval for XPOVIO ® in combination with bortezomib and dexamethasone (XVd) for the treatment of adult patients with multiple myeloma (MM) who have received at least one prior therapy marks ... 2025-07-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Interventional Robot's RCT Research Published in JNIS, a Leading Journal in Neurointervention! SHANGHAI , July 28, 2025 /PRNewswire/ -- The multicenter, randomized controlled trial (RCT) results of the PANVIS-A® NeuroInterventional Robotic System —led by Professor Liu Jianmin (Changhai ... 2025-07-28T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Embolx Launches Sniper G3: Revolutionizing Embolization with Enhanced Efficiency, Ease of Use, and Extended Shelf Life SUNNYVALE, Calif. , July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon ... 2025-07-28T Computer/Electronics Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Caliway Announces FDA Clearance of IND Application for CBL-514 to Proceed with SUPREME-01, the First Global Pivotal Phase 3 Study for Reducing Abdominal Subcutaneous Fat CBL-514, Caliway's first-in-class lipolysis drug candidate, has been granted clearance from the U.S. FDA to proceed with SUPREME-01, a global, multicenter, pivotal Phase 3 study. Subject recruitment is ... 2025-07-28T Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Medical/Pharmaceuticals